Novo Nordisk A/SNVONYSE
Loading
Research and development spending
3Y CAGR
+27.7%/yr
vs +12.9%/yr prior
5Y CAGR
+26.5%/yr
Consistent
Acceleration
+14.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $50.04B | +4.1% |
| 2024 | $48.06B | +48.1% |
| 2023 | $32.44B | +34.9% |
| 2022 | $24.05B | +35.3% |
| 2021 | $17.77B | +14.9% |
| 2020 | $15.46B | +8.7% |
| 2019 | $14.22B | -4.0% |
| 2018 | $14.80B | +5.6% |
| 2017 | $14.01B | -3.8% |
| 2016 | $14.56B | - |